CoChat

Treatment With Ursodeoxycholic Acid Is Associated With Weight Gain in Patients With Primary Biliary Cirrhosis

Siegel, Joanna L., Jorgensen, Roberta, Angulo, Paul, Lindor, Keith D. · 2003 · Journal of Clinical Gastroenterology

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Background Ursodeoxycholic acid (UDCA) is the established treatment of primary biliary cirrhosis (PBC) and is a safe and well-tolerated medication. Nevertheless, patients often anecdotally complain of weight gain while on this drug. Goals We compared weight changes in patients treated with UDCA and those on placebo to characterize this potential side effect. Study One-hundred eighty patients with PBC who were enrolled into a randomized, controlled trial received either UDCA (13-15 mg/kg/d) or an identical placebo. Changes from baseline weight were calculated at 12, 24, 36, and 48 months. Other markers of disease activity, including liver biochemistries, serum lipids, histologic stage, and Mayo Risk Score were evaluated in both groups. Results The proportion of patients who gained weight during the first 12 months of therapy was significantly greater in the UDCA than placebo group (67/86 [78%] versus 43/73 [57%] respectively, P = 0.005). Patients in the UDCA group gained an average of 3.6 +/- 6.5% kg (2.2 +/- 5.1 kg) which was significantly greater than the average of 0.6 +/- 6.9% kg (0.6 +/- 4.9 kg) gained in the placebo group (P = 0.04). The biggest change in weight occurred in the first 12 months of treatment (P Conclusion UDCA treatment in patients with PBC is associated with a significant weight gain that occurs in the first 12 months of treatment, persists for the duration of treatment, and occurs independent of baseline BMI. Discussions with PBC patients beginning UDCA…

Overview

Integrity signals

Registry

Crossref · 10.1097/00004836-200308000-00018

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 23 references

Research works printed but not linked: 3

  1. DiBaise, 1998, Am J Gastroenterol, 93, 2226
  2. Ginn, 1992, West J Med, 156, 547
  3. Behr, 1986, Am J Gastroenterol, 81, 796

Cited by

See all 40

Metadata

Authors
Siegel, J. L., Jorgensen, R., Angulo, P., & Lindor, K. D.
Affiliations
Mayo Clinic (US)
Corresponding author
Lindor, Keith D.
Venue
Journal of Clinical Gastroenterology
Published
2003-08
Volume
37
Issue
2
Pages
183-185
ISSN
0192-0790 (ISSN-L)
OpenAlex
W2054103320
Cited by
40
References
23
Citations by year
2026: 1 · 2024: 1 · 2023: 3 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 1 · 2014: 1 · 2013: 2 · 2012: 4
FWCI
0.66
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords
ursodeoxycholic acid, primary biliary cirrhosis, weight gain, adverse drug reactions, body mass index, disease activity, Mayo risk score, serum lipids
MeSH terms
Cholagogues and Choleretics, Female, Humans, Liver Cirrhosis, Biliary, Male, Middle Aged, Ursodeoxycholic Acid, Weight Gain, Body Mass Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment With Ursodeoxycholic Acid Is Associated With Weight Gain in Patients With Primary Biliary Cirrhosis. https://app.cochat.ai/papers/10.1097/00004836-200308000-00018
The paper
Siegel, J. L., Jorgensen, R., Angulo, P., & Lindor, K. D. (2003). Treatment With Ursodeoxycholic Acid Is Associated With Weight Gain in Patients With Primary Biliary Cirrhosis. Journal of Clinical Gastroenterology. https://doi.org/10.1097/00004836-200308000-00018

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.